Answering Criticisms of the Conservative Health Care Consensus Plan

The Center for American Progress recently released a study criticizing a Health Policy Consensus Group proposal to reduce premiums and increase choices for the millions of families and small businesses who are forced to choose between remaining uninsured or buying expensive Obamacare policies.The proposal, dubbed the Health Care Choices Proposal, would replace Obamacare individual...

A Surgical Approach To High Prescription Drug Prices

President Trump’s plan to lower prescription drug costs uses a surgeon’s scalpel to address a range of issues, offering nearly 30 policy recommendations to modernize payment policies, weed out counter-productive regulations, improve price transparency, and expand competitive price negotiations. The plan reflects the complexity of the industry and the regulatory system that governs government approval...

Rescuing seniors and Part D from Congress

President Trump delivered a major speech to describe steps his administration is taking to address the high cost of prescription drugs. Congress should be called on to fix two problems with the federal government’s largest prescription drug program: Medicare Part D. That program has made prescription medicines more affordable for millions of seniors, offering...

The Path Forward for Health Reform in 2018

An open letter to the American public from over 30 conservative leaders, whose names  are listed at the end. Congressional leaders were poised last month to spend tens of billions of dollars in the omnibus bill to temporarily shore up Obamacare’s failing health insurance system.That money, however, never would have given Americans the long-term...

Health Policy Consensus Group Calls For Renewability Of Short-Term Health Plan

Thirty-nine health policy experts and representatives of a broad cross-section of organizations joined in signing a comment letter to the Centers for Medicare and Medicaid Services regarding its proposed rule on Short-Term, Limited-Duration Insurance. They argue that the Obama administration exerted “regulatory overreach” in limiting the sale of short-term policies to 90 days and prohibiting...